According to the FDA, there are no FDA-approved GLP-1 patches, and if you can buy a product without a prescription, it is not an actual GLP-1 drug
Use 29-31 gauge insulin syringes for subcutaneous injections
Experts predict the scope of the litigation could encompass tens of thousands of claims by the end of 2025, reflecting the widespread use of GLP-1 medications
Hydration status: Nausea and reduced oral intake can lead to dehydration, potentially causing acute kidney injury, particularly in older adults
Gliptins may represent a valuable alternative to a sulfonylurea or a glitazone after failure of monotherapy with metformin while GLP-1 receptor agonists may be considered as a good alternative to insulin (especially in obese patients) after failure of a dual oral therapy
However, this may not be practical in all dental office settings